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ABSTRACT

Purpose: The prevalent disorder known as generalized anxiety disorder (GAD) can have various
negative consequences. GAD harms individuals, families, communities, and society as a whole.
People with GAD frequently experience a crippling decrease in their physical and mental health.
When generalized anxiety disorders are combined with the pressures of pre-existing medical
conditions, the quality of life can be significantly impacted. GAD severely impairs social and
functional functioning, resulting in frequent clinic appointments, doctor shopping, emergency
room visits, high costs from family and employer treatment, and increased costs for global
healthcare spending. Proper diagnosis is essential to effective treatment, and a lack of proper
diagnosis can cause issues not only for the patients but for the MNC Wellness center as well. These
include low productivity, increased costs, and poor cost management to the patient, affecting
customer focus and satisfaction and decreasing customer loyalty and retention. A quality
improvement project was designed to educate Psychiatric nurse practitioners at an outpatient
mental health clinic to increase their knowledge and the frequency of use of the GAD-7 screening
tool.
Background: To fill in the gaps in anxiety evaluation and outpatient mental care procedures, the
clinic adopted the frequency of use of the GAD-7 screening tool as a standard of care after the
educational intervention. The GAD-7 screening tool is a reliable, validated screening tool for
generalized anxiety disorder that enables prompt identification, the start of therapy, and referral to
behavioral health services. When used regularly in outpatient mental health settings, the GAD-7
can reduce tertiary care interventions, cut costs, and improve patient outcomes by lowering
anxiety-related dysfunction. The GAD-7 screening tool promotes measurement-based care, which
improves diagnostic efficacy and timeliness while promoting high-quality care.
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Methods: Sixteen psychiatric nurse practitioners voluntarily agreed to participate in an in-service
PowerPoint presentation to gain knowledge on the frequency of use of the GAD-7 screening tool.
The principal investigator collects pre- and post-chart review data from the EHR. The pre-and
post-chart review assessed existing and subsequent GAD-7 knowledge and frequency of use.
Descriptive statistics were used to analyze and interpret the pre-and post-chart review scores.
Results: The chart review shows improved knowledge and frequency of use of the GAD-7
screening tool. This enhanced their ability to assess patients for generalized anxiety disorder and
proper diagnosis to uphold the standard of care.
Conclusions: The education presentation effectively improved GAD-7 knowledge and the
frequency of use of the GAD-7 screening tool among the psychiatric nurse practitioners at the
MNC Wellness outpatient clinic. Increased provider knowledge enables successful GAD-7
implementation as part of routine, measurement-based care at the outpatient mental health clinic.
Continued GAD-7 tool use will improve results for the clinic, reducing a significant gap in
outpatient care delivery.

Keywords: GAD-7 screening tool measurement-based care, generalized anxiety disorder, GAD-7
screening tool and guidelines, GAD prevalence, the use of GAD-7 tool across the life span,
uphold the standard of care.
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SECTION ONE: INTRODUCTION

Generalized anxiety disorder (GAD) is one of the most common ailments that affect many
people daily. Due to frequent lifetime recurrence and symptom persistence, GAD can be
categorized as a chronic disorder. With prompt diagnosis and adequate treatment within the
integrated healthcare system, the significant expenses of GAD might be decreased. A reliable
screening tool designed to improve the knowledge of the psychiatric mental health practitioner
(PMHNP) in an outpatient mental health clinic is essential in strengthening proper diagnosis and
upholding standards of care. The generalized anxiety disorder 7-item screening tool (GAD-7) is a
validated tool that may detect improve the knowledge of the psychiatric mental health practitioner
(PMHNP) in an outpatient mental health clinic is essential a damaging effect on patients, families,
communities, and society at large (Sapra et al., 2020). GAD often brings a debilitating physical
and mental decline in those affected with the disorder. Combined with the stressors of preexisting
medical problems, generalized anxiety disorders can negatively influence the quality of life across
the lifespan. GAD causes severe interference and damage in social and functional settings, which
leads to frequent clinic visits, doctor shopping, emergency visits, high costs due to family
treatment, employers, and global healthcare spending. In MNC Wellness Center where the
research was conducted, the GAD-7 screening tool was used inconsistently, according to the initial
EHR data from their quality improvement report. Although the GAD-7 screening instrument was
integrated into the electronic health records (EHR) for documentation, the MNC Center uses it
inconsistently to diagnose anxiety, affecting patient satisfaction and decreasing customer loyalty
and retention. In the mental health outpatient clinic, mental health nurse practitioners' lack of
knowledge and frequency of use of the GAD-7 screening tool when diagnosing or treating their
patients was viewed as a gap.
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Background Knowledge
GAD is characterized by extreme anxiety with difficulties controlling emotions, and it is
complemented by observable symptoms such as irritability, difficulty concentrating, restlessness,
tiredness, and sleep disturbance (American Psychiatric Association [APA], 2013; Nyongesa et al.,
2020). GAD is one of the most prevalent mental health conditions in the United States, with an
annual prevalence rate of 6.8% or 3.1 million adults. Still, only about 43.2% are receiving care
(Anxiety and Depression Association of America, 2022). According to the National Institutes of
Mental Health (2022), approximately 5.7% of U.S. adults experience GAD at some point in their
lives, 32.2% have serious, 44.6% have moderate, and 23.1% have mild impairment. Statistics show
the lifetime prevalence of the generalized disorder among U.S. adolescents aged 13-18, which was
3.0% high in females than 1.5% in males. Research revealed that women were more likely than
men to develop an anxiety-type disorder showing 30.5-33% of women to 19-22% of men being
diagnosed (Jalnapurkar et al., 2018). GAD can occur at any given time in life, with differing
symptoms which co-occur with depression and other mixed anxiety disorders (APA, 2013). The
co-manifestation of the ailments often leads to multiple substance use, comorbidities, and
complicated deaths (Nyongesa et al., 2020). The disease is characterized by excessive,
uncontrolled worries about events that are difficult to control (Aljurbua et al., 2021; Moreno et al.,
2019; Ren et al., 2021). Bandelow and Michaelis (2022) revealed that according to extensive
population-based surveys, 33.7% of the population is affected by anxiety during their lifetime. The
prevalence of GAD in the general population ranges from 0.4 to 5.7% (Nyongesa et al., 2020). In
outpatient practices, most GAD symptoms range from 3.7 to 14.8%, accounting for about half of
the disorder in these settings. Research shows that 23% is reported in high-income settings, while
30% is seen in low and middle-income countries. The presence of the disorder can elevate the
mortality rate among different age groups (Chang et al., 2017). Patients with anxiety disorders may
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have a poor quality of life as evidenced by deteriorating psychological discomfort, physical health
decline, living disability, and poor ability to follow or adhere to the treatment regimen (Chang et
al., 2017). GAD related to comorbidity can be particularly daunting and impede the patients'
functionality leading to high direct medical services and indirect cost of living (Sinnema et al.,
2018). Due to the high occurrence of these mental disorders, many countries suffer from the high
cost of treatment. Research shows that the United States is estimated to spend $42.3 billion on
people suffering from the disorder annually (Łoś & Waszkiewicz, 2021).
GAD can be considered a chronic condition as evidenced by the disease symptom
recurrence throughout the patient's lifetime (Ahn et al., 2019). Some patients with GAD suffer
considerable dissatisfaction throughout their lives, low-income family relationships, and low work
productivity (Nyongesa et al., 2020). Many people with GAD receive either no mental health
treatment or inappropriate treatment. If GAD is undermanaged or untreated, the symptoms can
influence self-care, help-seeking behavior, and interpersonal functioning (Calear et al., 2021). The
review found that the treatment gap for GAD is a global problem. A sample result from 51,547
participants in 21 nations reveals that 9.8% had an anxiety illness the year before and that 27.6%
had gotten therapy (Moreno et al., 2019). A cross-sectional study revealed that people who
experienced at least a 12-month period of GAD conveyed an inability to execute their typical role
on an average of 41.2 days per year, and 50.6% of respondents described severe malfunction due
to GAD (Ruscio et al., 2017). Due to the high incidence of these mental disorders, many countries
suffer from the high cost of treatment. The United States is anticipated to spend $42.3 billion
annually, which highlights the burden on the healthcare system caused by the rising usage of
resources to treat anxiety disorders. (Łoś & Waszkiewicz, 2021).
At the MNC Wellness center, despite the presence of the GAD-7 screening tool embedded
in the EHR, the use of it was limited due to a lack of knowledge of the tool's benefits, resulting in
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declining patient loyalty, poor patient satisfaction, and patient retention, as reported by the MNC
Wellness center director. The undesirable effect of GAD on illness from co-occurring conditions
mount healthcare costs, as evidenced by the annual median medical bill estimated at $2375
compared to $1448 for those without GAD (Kehoe, 2017). People with untreated or undiagnosed
GAD misuse healthcare resources, resulting in costly emergency department visits. In addition to
the organization’s infrequent use of the GAD-7 screening tool, the underuse affects the clinic’s
higher productivity, increased costs, and poor cost management to the patient, affecting customer
focus and satisfaction and decreasing customer loyalty and retention.
A GAD-7 screening tool is a standardized tool that can effectively screen all patients for
GAD, allowing for proper, timely diagnosis, treatment commencement, and therapist referral, not
only in primary care institutions but in all mental health settings (Ahn et al., 2019; Bischoff et al.,
2020; Johnson et al., 2019). The high spending on GAD can be decreased with timely diagnosis
and appropriate management of conditions within the outpatient mental health system. Due to the
GAD-7 tool’s diagnostic reliability, factorial, construct, and criterion validity are today known as
the most widely used anxiety measure in clinical practice and research (Toussaint et al., 2020).
The American Psychiatric Association recommends it as a useful screening tool for measuring the
severity of GAD (APA, 2013). The ability of the GAD-7 screening tool to detect a significant
change in health status after an assessment is essential to the outcome measure. Research revealed
that measures such as the difference in GAD-7 scores before and after an intervention underpin its
practical and valid use in assessing anxiety outcomes in an outpatient mental health clinic
(Toussaint et al., 2020). According to Toussaint et al. (2020), the sensitivity to change of the GAD7 tool demonstrates its utility as an efficient and economic severity measure for anxiety.
As documented by the Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition (DSM-V) criteria, the GAD-7 is a seven-item questionnaire that clinicians can use to
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identify people with GAD efficiently. Their reliability and validity report a best-fitting for a onefactor structure with a strong level of sensitivity (89%) and specificity (82%), whereas others said
a two-factor model (Moreno et al., 2019; Seritan et al., 2018). Coexisting mental health disorders
such as GAD led to deteriorated medical issues, impaired physical function, increased utilization
of healthcare resources, and patient and family suffering (Veisy et al., 2021). Continuous use of
the GAD-7 screening tool during each visit, new visits, and yearly visits will alleviate or prevent
GAD-induced malfunctioning, decrease specialized interventions, and improve patient outcomes
(Veisy et al., 2021). The outpatient mental health clinic will be the primary place to encounter the
signs and symptoms of the disease, which, if not adequately diagnosed, can lead to increased
morbidity and mortality (Moreno et al., 2019).
Additionally, the GAD-7 is one of the most extensively used anxiety measures in research
and clinical practice. It can be used for anxiety disorder screening, diagnosis, and severity
evaluation, including social phobia, post-traumatic stress disorder, panic disorder, and GAD
(where scores of 10 or higher indicate GAD). The American Psychiatric Association has recently
suggested the GAD-7 as a suitable tool for assessing the severity of GAD in accordance with the
updated DSM-V criteria (APA, 2013). Routine implementation of the GAD-7 screening tool
during those visits can allay other prevalent problems of GAD (Budikayanti et al., 2019). The role
of assessment in using the GAD-7 screening tool is deviated to the practitioners and away from
those consulting who, in one way or the other, cannot speak regarding their symptoms. The stigma
associated with mental health ailments and patients' lack of knowledge about their symptoms may
hinder seeking proper treatment (Maunder & White, 2019; Mughal et al., 2020). Practitioners
tackling anxiety disorder by routinely screening using a standardized tool before initiating
treatment take away the burden from patients and decrease stigma-related vulnerability (Nyongesa
et al., 2020; Toussaint et al., 2020). Utilizing educational awareness to increase practitioners'
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knowledge and frequency of use of the GAD-7 tool to assess mental health-related conditions such
as GAD can reduce the rate of under-diagnosed and under-treatment in a mental health outpatient
clinic (Bischoff et al., 2020; Mughal et al., 2020). Research revealed that GAD-7 questionnaires
are quick to administer, enhance time efficiency, and maintain good sensitivity and specificity for
diagnosing the most common anxiety disorders encountered in psychiatric outpatient mental health
clinics (Sapra et al., 2020). However, due to a lack of knowledge and the vacillation to follow
protocol by practitioners, educational interventions are an efficient way to increase practitioners'
knowledge and frequency of use of the GAD-7 screening tool to support proper diagnosing and
uphold standards of care. According to Cullen et al. (2020), training and mentoring healthcare
practitioners positively impact evidence-based practice adoption.
Problem Statement
The DNP project was developed to fill in the gap that accounts for a significant decrease
in the quality of evidence-based practice use at the outpatient mental health clinic. The project
occurred in a mental health outpatient clinic in Maryland, the Mid-Atlantic region of the United
States East Coast. The GAD-7 screening tool was used to maintain good sensitivity and specificity
of the diagnosis and enhance the time efficiency of the most common anxiety disorders
encountered in outpatient mental health clinics (Sapra et al., 2020). The GAD-7 screening tool,
integrated into the electronic health records (EHR) for documentation, was inconsistently used in
the mental health outpatient clinic to identify anxiety completely. The initial EHR data from their
quality improvement report showed inconsistent utilization of the GAD-7 tool. The mental health
outpatient clinic's gap was illuminated by mental health nurse practitioners' lack of knowledge and
frequency of use of the GAD-7 screening tool when diagnosing or providing care to their patients.
The recommended standard for screening using the GAD-7 tool in population and trials focusing
on anxiety-specific treatment is highly recommended for all psychiatric mental health nurse
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practitioners to support proper diagnosing and uphold the standards of care (Toussaint et al., 2020;
Johnson et al., 2019).
The significance of education to psychiatric nurse practitioners (PMHNP) toward attaining
competency in anxiety screening tools could not be overemphasized. The magnitude of this
educational project was that it would improve practitioners' knowledge and frequency of use in the
implementation of the GAD-7 screening tool, making it easier to identify, diagnose, and treat
anxiety (Hinz et al., 2017). Research revealed that the frequency of use of the GAD-7 tool supports
proper diagnosis and upholds standards of care (Toussaint et al., 2020). An outcome measure must
meet the necessary condition of sensitivity to identify significant changes in health status over
time. This would support its practical and reliable application for evaluating anxiety outcomes in
studies and clinical work. Despite the pervasiveness of anxiety in the United States and the clearcut standards regarding the utilization of the GAD-7 tool, practitioners continue to battle to
implement the GAD-7 screening tool in practice (Hinz et al., 2017; Łoś & Waszkiewicz, 2021;
Shevlin et al., 2022).
The GAD-7 is essential for psychiatric care settings because it is effective as a screening
tool and measures the intensity of symptoms for the four most prevalent anxiety disorders—GAD,
panic disorder, social phobia, and post-traumatic stress disorder. The importance of the GAD-7
tool to the mental health outpatient clinic and the profession was proven by the fact that education
to the psychiatric nurse practitioners not only supported their understanding of the tool but
increased their knowledge and frequency of use of the tool to practice autonomously when
prescribing treatment for anxiety. The GAD-7 knowledge supports proper diagnosis and upheld
standards of care (Toussaint et al., 2022). According to Johnson et al. (2019), the GAD-7 showed
strong internal consistency and convergent validity. The associations discovered in this study,
which range from r = 0.62 for related constructs to r = 0.70 for anxiety disorders, are comparable
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to those identified in earlier investigations. Furthermore, the study intake and post-treatment alphas
were all over 0.82, and there were strong associations with other measures of anxiety and wellbeing, indicating excellent reliability and validity. The GAD-7 thus proved to have convergent
validity.
Additionally, the discriminant validity of GAD-7 shows a good separation between an
anxious and a broader psychiatric group. This study's clinical implications include the ability to
use the GAD-7 to gauge anxiety intensity. Scores of eight and higher may suggest the presence of
an anxiety condition and call for additional follow -up. The measurements' versatility is another
benefit, as patients’ diagnoses in psychiatric mental health outpatient clinics are frequently
complicated and comorbid. The GAD-7 offers several benefits to clinicians in an outpatient
psychiatric mental health clinic, including being simple to use, having distinct psychometric
features, and having seven items. Clinicians can adopt it without risk, and the practitioners'
education on the use of GAD-7 screening tools increases the wellness of their patients and prevent
impartiality. In addition, the GAD-7 tool knowledge improvement by the practitioners invariably
would improve customer loyalty and retention, customer focus and satisfaction, increase
profitability, improve practitioners' morale, and greater efficiency and outcomes for the clinic.
Purpose of the Project
The gap in the mental health outpatient clinic was a lack of knowledge and frequency of
use of the GAD-7 screening tool amongst PMHNP which affected effective standards of care.
Therefore, the DNP project's proposed goal was to minimize the gap through a quality
improvement educational program to increase PMHNPs' knowledge and frequency of tool use.
Implementing the frequency of use of the GAD-7 tool by PMHNP practitioners would establish a
standardized practice that would strengthen PMHNP practitioners’ ability to evaluate anxiety and
begin appropriate services. Standardizing care and making sensible use of the clinic's current
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resources would form a more effective and efficient system for providing patient care. This will
also boost organizational profitability owing to patient retention and the clinic's efficiency and
results. A screening tool that easily connects to the EHR will significantly enhance the outpatient
clinic. It hypothesized that the DNP project's purpose statement answered the following practicefocused clinical question (PFQ):
PFQ: For psychiatric nurse practitioners in a mental health outpatient clinic, will an
educational intervention improve knowledge and frequency of use of the GAD-7 screening tool,
which would strengthen proper diagnosis and uphold standards of care?
The DNP project focused on the gap in practice by advocating for GAD-7 screening tools
and better outcomes through early detection, diagnosis, and appropriate medication management
of anxiety. The project taught the PMHNP the importance of the use of GAD-7 in the management
of anxiety disorder. Completing the DNP project also increases practitioners' frequency of use of
the tool when assessing and treating those affected with anxiety. The goal was for practitioners to
understand the benefits of using the GAD-7 screening tool during an assessment to enhance the
clinic's standards of care and profitability to the clinic owing to patient retention and satisfaction.
Clinical Question
For Psychiatric nurse practitioners in a mental health outpatient clinic, will an educational
intervention improve knowledge and frequency of use of the GAD-7 screening tool, which will
strengthen proper diagnosis and uphold standards of care?
DNP Essentials Addressed
The strength of this scholarly project was its strong link to the Doctor of Nursing Practice
(DNP) Essentials fundamental to the DNP practice and interwoven throughout the DNP program.
The DNP Essential I: Scientific Underpinnings for Practice asserts that nursing practice at the
doctorate level is immersed in scientific expertise (American Association of Colleges of Nursing
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[AACN], 2006). This scholarly project meets DNP essential I through the improvement of an EBPbased quality improvement education program that directly impacts a mental health outpatient
clinical practice site.
The scholarly project provided a quality EBP educational intervention program on a tool
that improved an organization's outcome that operates as a mental healthcare outpatient clinic. It
aligns with the DNP Essential II as an evidence-based quality improvement project implemented
in a mental health outpatient clinic system. Essential II states that the Organizational and System
Leadership for Quality Improvement and System Thinking must know how to work and collaborate
with others within an organization. The DNP project supports the organization and the
practitioners and upholds the standards of care (AACN, 2006).
DNP Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based
Practice utilize various scholarly pursuits and investigate evidence to promote EBP (AACN,
2006). Using a quality researched screening tool such as GAD-7, it sought to support the education
of mental health practitioners on the frequency of use to create a practice based on EBP.
The DNP Essential IV: Information Systems/Technology and Patient Care Technology for
the Improvement and Transformation of Health Care involves the understanding and using
healthcare technology within any healthcare system (AACN, 2006). The scholarly project used
technology to search the frequency of use of the GAD-7 by all mental health practitioners before
and after chart use. The project included how the PMHNP mental health nurse practitioners used
the current electronic health record system to obtain the GAD-7 data from each patient
electronically. The project required the use of technology to deliver academic knowledge.
The DNP Essential VI: Interprofessional Collaboration for Improving Patient and
Population Health Outcomes allows providers to work with the interdisciplinary team to deliver
and improve patient healthcare outcomes (AACN, 2006). The scholarly project is geared in
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collaboration with the PMHNP mental healthcare practitioners and other stakeholders (Director
and the information Technology staff) via an educational program about the screening tool used
in an outpatient mental health clinic.
The DNP Essential VII: Clinical Prevention and Population Health for Improving the
Nation’s Health assists in preventing disease and promoting patient health. The quality
improvement project embedded within these essentials focused on a population affected by
specific mental health problems. Education was provided on a screening tool that strengthened
proper diagnosis and upheld the standard of care. Other measures included evaluating care delivery
models using concepts related to community and social-economic proportions of health. This
essential entwined with population health was crucial to advancing organizational healthcare
processes (AACN, 2006).
The DNP Essential VIII: Advanced Nursing Practice prepares DNP practitioners to utilize
their advanced nursing skills and apply them across various settings or systems (AACN, 2006).
Essential VIII employed an advanced practitioner to provide an educational program to the
PMHNP mental healthcare practitioners in an outpatient mental health clinic. This improved
knowledge and frequency of use of the GAD-7 screening tool offered an advanced level of
evidence-based practice to all patients.
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SECTION TWO: LITERATURE REVIEW
Search Strategy
A literature search was conducted to pinpoint evidence of GAD prevalence, GAD-7
guidelines for accurately diagnosing, and the use of GAD-7 screening tool across the lifespan in
mental health outpatient settings associated with practitioners' education. The evidence searched
employs the database of CINAHL, MEDLINE w/Full text (EBSCO), PsychInfo, and
PyschArticles. For all data, the criteria included were limited to publication within five years,
academic journals, peer-review articles, GAD-7 assessment screening tool, the standard of care
for mental health practitioners, quality improvement for outpatient mental health, educational
interventions with staff, as well as all age inclusion in the study of the project. The article search
included the use of "GAD-7," "generalized anxiety disorder," "GAD-7 screening tool for a proper
diagnosis," and "GAD-7 screening tool." The Boolean/phrase and keywords common during the
search included “a measurement-based tool in mental health office/clinics", “standard of care” and
"GAD-7 in mental health outpatient practice.” The literature search provided an overview of
standardized evidence showing that practitioner's education modules can increase knowledge and
frequency of use of the GAD-7 screening tool to correctly identify, diagnose, and treat anxiety in
a mental health outpatient setting.
The initial CINAHL search on generalized anxiety disorders returned 2.875 studies, but
after typing GAD-7, it produced 325 results. Adding "screening tool" to the Boolean/phrase
yielded 14 results which were then reviewed carefully. Many of the documents were rejected
because of duplications or reviews of studies, while four were eliminated. Ultimately, eight studies
were found vital for the DNP project.
MEDLINE w/Full-text (EBSCO) was similarly searched with a keyword initial "GAD-7"
and returned 6,074 documents. The years of publication were changed to 2017 and later with no
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age specifications. Additional Boolean/phrases "GAD-7 and outpatient practice" were added to
narrow the search documents that yielded 11 studies for scrutiny. These results were then
individually examined for excellence.
The PsychInfo and PyschArticles databases were investigated by applying the same
methodology. These searches generated 26 articles, respectively. Search phrases such as "GAD-7
screening tool and guidelines, GAD prevalence, the use of GAD-7 tool across the life span in
mental health outpatient settings and associated patient outcomes" came up faster, defeating the
purpose of making multiple inquiries for peer review articles. The majority of the articles were
published within five years. The retaining searches centered on validity and reliability within an
outpatient setting.
Critical Appraisal
All studies retained for this critical appraisal prove the prevalence of GAD worldwide and
the authenticity of the GAD-7 use in different practice settings. Some of the research studies' main
findings and outcomes concluded that the GAD-7 screening tool was extensively validated in
assessing and treating anxiety symptoms across different settings (Johnson et al., 2019). Research
using the GAD-7 screening tool showed 68% sensitivity and 88% specificity of any anxiety
disorder (Sapra et al., 2020). Research showed that the frequency of use of the GAD-7 in screening
patients with anxiety promotes prompt quality treatment methodology (Spitzer et al., 2006). The
effectiveness of health care screenings is significantly constrained in the absence of coordination,
consistency, and standardization. The gaps between the annual and lifetime prevalence rates with
treatment rates suggest that millions of people with GAD are undiagnosed and suffering, making
accurate and prompt GAD screening critical for all adults (Ruscio et al., 2017). The gap in the
mental health outpatient clinic was a lack of knowledge and infrequent use of the GAD-7 screening
instrument by PMHNP, which had an impact on efficient standards of service.
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To close this gap in care, psychiatric mental health practitioners utilized a GAD-7
screening tool to help them evaluate GAD symptoms. Measurement-based care (MBC) aims to
accelerate and improve diagnostic accuracy, enabling high-quality care with the least amount of
financial and patient stress (Martin- Cook et al., 2021). MBC can be used in routine care regardless
of the patient demographic, treatment type, philosophy, or practitioners’ educational background
because it is both transdiagnostic and transtheoretical. MBC can improve functioning and quality
of life when incorporated into routine care, promoting patients' active participation in the healing
process.
Healthcare organizations can enhance patient care delivery, have a favorable influence on
patients, and spend less on tertiary care by using an MBC tool like the GAD-7. Healthcare
companies cannot readily assess the performance of the quality improvement project or prove to
payers that their therapies are beneficial without MBC procedures (Martin-Cook et al., 2021).
Integrating MBC with precise benchmarks and measurements into clinical practice will enhance
service reimbursement in the psychiatric mental health clinic (Martin-Cook et al., 2021).
Synthesis
The literature reviews provided a direction for the educational module that taught the
PMHNP nurse practitioners about the frequency of use of the GAD-7 screening tool. Research
supports that the GAD-7 was suggested for use in clinical research and routines and to detect
improvement in care delivery in an outpatient mental health clinic (Sapra et al., 2020; Toussaint
et al., 2020). Johnson and colleagues (2019) suggested that accurately screening for anxiety leads
to effective early diagnosis and upholding the standard of care. The goal of the quality
improvement (QI) initiative was to improve the understanding of psychiatric mental health
practitioners working in outpatient psychiatric clinics to utilize the validated, evidence-based
GAD-7 in assessing their patients. The MBC standard of care ensures that all patients receive
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proper anxiety assessment using the GAD-7 to screen patients who visit the clinic (Martin-Cook
et al., 2021). The clinic's psychiatric mental health practitioners received their initial training after
the principal investigator’s pre-chart review (see table 1 findings) during a brief presentation in
the conference room, which encouraged frequent use of the GAD-7 screening tool to uphold
standards of care. Hence, one could not underestimate the importance of educating PMHNP nurse
practitioners to accomplish competency levels using the GAD-7 screening tool to strengthen the
proper diagnosis.
A thorough review of current scholarly articles on the reduced usage of and poor devotion
to the GAD-7 standardized tool indicated the level of the problem surrounding the screening
methodology, the significance of the issue, the evidence-based practice used to manage the
problem, and the evidence-based practice needed to address the problem (Hinz et al., 2017).
Mughal and colleagues (2020) researched the validity of GAD-7 screening tools for anxiety and
post-traumatic stress disorder, thereby contributing significantly to disability-adjusted life years in
low-to-middle-income countries. To further bolsters the reliability of GAD-7, the research was
conducted via a systematic review where accurate results were organized based on the screening
tool, cut-off, and specific disorder. In the study, only two validations with identical cut-off scores
for the GAD-7 tool could be mixed via meta- analysis. No other validations of similar cut-off
values provided enough information to conduct a meta-analysis. Therefore, practitioners were
required to identify the exact version used when running the validity of the screening tool. The
literature review unveils records used to build the educational program and answer the practicefocused question (Bischoff et al., 2020; Hinz et al., 2017; Moreno et al., 2019; Nyongesa et al.,
2020). The results of the GAD-7 questionnaire show the existence of the DSM-V-listed GAD
symptoms. The criteria for GAD did not change significantly compared to DSM-IV even though
the anxiety disorder spectrum was reorganized in the DSM-V into separate groupings for the
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classical anxiety disorders, trauma- and stressor-related disorders, obsessive-compulsive and
related disorders, and dissociative disorders. To determine the level of burden experienced by both
individuals and patient groups, a questionnaire's normative values are crucial (Hinz et al., 2017).
Research proved that GAD-7 allowed for a classified assessment of the symptoms of anxiety and
treatment modalities. The GAD-7 has been validated in outpatient settings and used successfully
in mental health clinics. The GAD-7 anxiety screening tool was user-friendly for all practitioners
or clinicians. The practitioners used GAD-7 during the initial visit, which assists in the
identification of both objective and subjective signs and symptoms, proper diagnosis, and followup visits to roll out unresponsive symptoms. The GAD-7 screening tool developed by Spitzer,
Kroenke, Williams, and Lowe in 2006 is free and accessed online (Spitzer et al., 2006). GAD-7
had seven items that measured the severity of different presenting signs and symptoms of GAD
following the reported response categories with allocated points. Additionally, research affirms
that educational intervention will foster professional growth and interprofessional teams, assist
point-of-care practitioners in functioning as change agents applying EBP in daily practice, and
promote retention (Cullen et al., 2022).
Conceptual Framework/Model
A conceptual framework was essential in developing a quality improvement (QI) project.
The Iowa model was used to guide the GAD-7 project. The Iowa model of evidence-based practice
is a system of approach that clarifies how an organization's practice changes to maintain QI and
has been used in plenty of settings to promote the implementation of evidence-based practice
(Cullen et al., 2022; White et al., 2019). The phases of the Iowa model, which consists of seven
processes, encourage the establishment of interprofessional teams, the review, critique, and
synthesis of the available evidence, the implementation of change through pilot projects, ongoing
evaluation, and distribution of the results. The reason for using the Iowa model stands as an
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evaluation model that supports projects designed to teach practitioners and improve the frequency
of use of the GAD-7 screening tool. The model operates ideally within an organizational
standpoint, as evidenced by providing directions to practitioners in everyday decision-making. The
model provides opportunities for the practitioners to pay close attention to the knowledge and
question existing healthcare practices to see if they could make a change by introducing current
research practices (Cullen et al., 2020; Cullen et al., 2022). The Iowa modal focused on an
interdisciplinary approach rather than an individual perspective to guide evidence-based decisionmaking. Using this Iowa model to implement the GAD-7 screening tool assisted the practitioners
in questioning their existing knowledge and frequency of use to improve current evidence-based
research findings (Cullen et al., 2022).
The model's first step was identifying a problem that needs change by identifying the
clinical practice question triggered by a problem in the outpatient clinical setting. In the MNC
Wellness center, does an educational program for psychiatric nurse practitioners in an outpatient
mental health clinic increase their knowledge of and frequency of use of the GAD-7 screening
instrument, to enhance accurate diagnosis and uphold standards of care? It was vital to understand
that some problems were knowledge-triggered while others were problem-triggered. Problemfocused generate original clinical problems, while knowledge -focused triggers originate when
new practice recommendations were needed (Cullen et al., 2022). With insufficient evidence to
support the project, a literature search was required. Another step was to test the recent practice
change; if effective, the difference could be applied to organizational practice. Continuous
evaluation of the change was needed weeks to months after the implementation. PMHNP at the
outpatient mental health clinic managed patients with anxiety. However, increasing
practitioners' knowledge and frequency of use of the GAD-7 screening tool strengthens proper
diagnosis and upholds standards of care.
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Theoretical Framework
A theoretical framework is vital in guiding a principal investigator in analyzing scholarly
research. Varpio and colleagues (2020) posit that theoretical foundations stem from one or more
theories created to support a study. A theoretical framework was necessary to improve awareness
of the proposed solution to the identified clinical problem for PMHNP nurse practitioners to
effectively merge research evidence into clinical practice. Bandura’s social cognitive theory
provides the capacity to exercise control over this project (Bandura, 1977). The primary concept
of this theory is self-efficacy which refers to an individual belief system to succeed in certain
situations or realize set goals. Self-efficacy refers to asserted capabilities to learn or execute actions
at specified levels (Schunk & DiBenedetto, 2021). Self-efficacy inspires the way individuals feel,
think, and enthuse themselves to achieve set goals (Bandura, 1994). Li (2020) states that selfefficacy is central to goal setting, enactment, attainment, self-efficacy theory, and reliable
treatment targets.
A robust sense of self-efficacy improves individual or group achievements in numerous
ways. Individuals with a high-ranking common sense of assurance in their skills were likely to
view complex tasks as a challenge to overcome rather than threats that should be avoided.
According to Schunk and DiBenedetto (2021), the most trustworthy information comes from
performance successes since they show what a person is capable of. The self-efficacy of witnesses
can increase after seeing a successful performance. In contrast, individuals with a high sagacity of
self-efficacy established their goals and endured firm promises even when confronted with a
fiasco. They ascribe failure to the absence of skills and knowledge which can be acquired and
quickly recover their sense of self-efficacy after experiencing setbacks. At MNC Wellness Center,
seven of the sixteen participants have less than two years of experience using the GAD-7 screening
tool, while the remaining nine have five years of experience. Even with those years of experience,
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the participants need to gain the knowledge of proper completion and benefits of the frequency of
use of the GAD-7 tool. People are less skillful in the beginning phases of learning; thus, they must
persevere to succeed. Before experiencing setbacks. At MNC Wellness Center, seven of the
sixteen participants have less than two years of experience using the research have significantly
advanced our knowledge of human motivation. Researchers have found that a significant internal
motivational process called self-efficacy influences the motivational outcomes of decisions, effort,
persistence, and performance. Personal and contextual factors can control self-efficacy. Applying
self-efficacy principles to various circumstances indicates that the basic idea needs certain
modifications. Furthermore, such positivity improves personal success, decreases stress, and
reduces the vulnerability of practitioners’ lack of knowledge and frequency of use of the GAD-7
screening tool.
On the contrary, individuals who question their capabilities to perform tasks coy away from
complex tasks, regarding them as personal risks to be avoided. When faced with trials, individuals
may tend to focus on their deficiencies. They may slowly regain their sense of self-efficacy and be
subject to minimal interest in using the GAD-7 screening tool properly or frequently as deemed.
According to Eun (2019), behaviors, external events, and internal personal characteristics like
cognitive, affective, and biological occurrences all function as interdependent determinants that
affect one another in both directions. An individual's unique characteristics, such as their particular
cognitive abilities and affective tendencies, all influence the kinds of environments and activities
they will choose to engage in within those environments. In a continuous process of reciprocal
effect, these decisions also impact how cognitive and affective processes evolve in the future. One
may argue that individuals with a high feeling of self-efficacy are more likely to participate in
educational training that enhances psychiatric nurse practitioners' understanding and frequency of
use of the GAD-7 screening tool. The practitioners are likely to attend GAD-7 screening training
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sessions and participate in scholarly projects to support proper diagnosis and uphold standards of
care. The social cognitive theory points out that self-efficacy can be spawned from diverse sources
such as verbal persuasion, vicarious experiences, physiological state, and performance
achievement (Bandura, 1977). As the principal investigator, I used verbal persuasion and modeled
acceptable behavior to improve practitioners’ capability to participate in the quality improvement
project.
Summary
The practitioners have a crucial role in addressing the diagnosis and management of
patients affected with anxiety in an outpatient mental health clinic. The section below discusses
the project outlines and the doctoral proposal plan for introducing the plan, collecting, and
analyzing the data. The area will document a well-defined evidence-based source to prove how it
can ethically use current evidence to improve the frequency of use of the GAD-7 screening tool in
an outpatient mental health clinic to support proper diagnosis and uphold standards of care.
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SECTION THREE: METHODOLOGY
Design
The quality improvement project was designed to improve practitioners' knowledge at an
outpatient mental health clinic before implementing the GAD-7 screening tool that supports proper
diagnosing and upholds standards of care (Antony et al., 2019; Wackerbarth et al., 2021).
Implanted in the electronic health record, the GAD-7 tool was integrated into the practitioners'
daily workflow to ensure that screening was completed with each patient at the initial consultation,
during clinic visits, and annually. Having the GAD-7 software embedded in the clinic system for
easy use and reliability aligns with the lean-startup management model for the clinic (Antony et
al., 2019; Sapra et al., 2020; Wackerbarth et al., 2021). The key stakeholders of the outpatient
mental health clinic agreed to the introduction of the GAD-7 tool frequency of use. They supported
the idea of the project bringing quality improvement aimed at improving the practitioners'
knowledge of the frequency of use of the tool and the importance of each patient's diagnosis and
treatment. The principal investigator identified the underuse of the GAD-7 in GAD care as the
existing gap and petitioned that the clinic administration should position the GAD-7 screening tool
in the patients' dashboard for daily assessment and easy access. This broad quality improvement
project was developed following the principal investigator’s role as a Doctor of Nursing Practice
student. The Information Technology (IT) department used its expertise to assist graduates in
implementing the scholarly project. The principal investigator's role was to provide the opportunity
to create and deliver educational interventions.
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The design for this project was a quasi-experimental quantitative analysis. The principal
investigator started with a lunch and learned session discussing the project with about eighteen
PMHNP nurse practitioners at the outpatient mental health clinic. Before introducing the QI
project and eliminating bias, the principal investigator randomly, with the help of an information
technology department staff, picked charts diagnosed with GAD or anxiety three months before to
evaluate practitioners' daily diagnosing and treatment routine. On the scheduled date of the
presentation, it was strongly advised that all practitioners be present. A week later, the principal
investigator initiated a 45-minutes PowerPoint educational presentation to PMHNP nurse
practitioners on the Knowledge and frequency of use of the GAD-7 screening tool. The pre-chart
review results were used for this project to ascertain practitioners' knowledge and frequency of use
of the GAD-7 screening tool to diagnose and uphold the standard of care in an outpatient mental
health clinic. A post-chart review was initiated at various times; week one, week three, week five,
and week seven to evaluate progress toward their improved knowledge level and frequency of use
of the GAD-7 screening tool. The outcome of the scholarly project was measured using the postchart review, which included the frequency of use of the GAD-7 screening tool.
Measurable Outcomes
The scholarly project sought to improve the practitioners' knowledge and frequency of use
of the GAD-7 screening tool to support proper diagnosis and uphold standards of care. The
paired t-test was used for the pre-and post-chart review analysis. The pre-and post-chart review
compares knowledge and frequency of use of the GAD-7 screening tool by the PMHNP nurse
practitioners before and after the PowerPoint educational presentation. The review of the results
from the charts enhances the application of the daily screening tool at the outpatient mental health
clinic by the PMHNP nurse practitioners.
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The first measure during this EBP scholarly project was considered the practitioners'
baseline frequency of use of the GAD-7 screening tool. The frequency was measured in weeks
using the t-test. The principal investigator determined the outcome using the paired sample ttest analysis following the educational intervention. A post-chart review was started at different
weeks—weeks one, three, five, and seven to assess progress made toward PMHNPs' increased
knowledge level and frequency of use of the GAD-7 screening tool (see table 3-final analysis).
Setting
The scholarly project occurred in a mental health outpatient clinic in Maryland, on the East
Coast's Mid-Atlantic region. MNC Wellness center hosts approximately forty clinical and nonclinical staff of males and females ages 20 to 50. MNC Wellness center is operated by a clinical
director, head of finance, IT, and the human resources department. MNC Wellness center sees
patients affected by various mental illnesses, and all documentation is completed via EHR. MNC
Wellness center's mission is to provide the best care to every patient through integrated clinical
practice and education. Also, the organization value commitment to integrity and ethical practice,
compassion, commitment to excellence, respect for persons, and justice in healthcare. The goal of
the scholarly project was to close the gap in the frequency of use of the GAD-7 tool, which supports
the mission and values of the organization.
The principal investigator completed a background assessment of the treatment population
across the lifespan at the MNC Wellness outpatient clinic's approach to using the GAD-7 screening
tool and a signed site agreement for permission to conduct the project. The principal investigator
receives an IRB approval letter from Liberty University to conduct the scholarly project. The
principal investigator informed the participants that project participation was voluntary and that
each member could withdraw at any time.
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The current method of using the GAD-7 screening tool at the outpatient mental health clinic
was examined. Previous data was screened for gaps anonymously as approved by the medical
director. The principal investigator collaborated with the medical director to agree on the content
of the educational presentation, and I led the development project. The principal investigator
reviews and examines the literature while identifying the areas that need support. The Iowa EBP
model was used to guide the project's goal. Before bringing it to the team, I reviewed the
PowerPoint presentation based on pre-chart review data (see table 1 findings) for clarity,
simplicity, content appropriateness, formatting, and style. A 45-minute PowerPoint Presentation
addresses the gap identified at the pre-chart review.
The principal investigator's pre-chart review that covers three months (May to July 2022)
worth of documentation of the use of the GAD-7 tool by the participants was done from August
22nd to the 29th after the approval of the IRB. The pre-chart review needed one week to gather all
the necessary information regarding the gap in the GAD-7 screening tool before an educational
session. The eighteen PMHNP nurse practitioners verbally agreed to sign a consent form to
participate in the educational project. However, only sixteen psychiatric nurse practitioners
participated, and the clinic did not explain why the two did not show up. I clarified the nature of
the project to those who agreed to participate before the chart review.
The anticipated outcome of this project was for the practitioners to gain knowledge that
would increase the use of GAD-7 screening tool. The data were analyzed for seven weeks using
Microsoft Excel to build a statistical record showing the validity and reliability of new evidencebased knowledge for the outpatient mental health clinic. After the quality improvement
intervention, I presented the team's pre- and post-chart review results.
Population
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The approach for this project supported the psychiatric nurse practitioners in using the
GAD-7 tool in the organization for properly diagnosing and upholding standards of care. As the
principal investigator, I have four years of experience as a family practitioner and a 15-year work
history in an inpatient mental health facility. All sixteen practitioners in the educational program
were psychiatric mental health (PMHNP) nurse practitioners at the MNC Wellness center
outpatient mental health clinic where the project took place. The average age was 30 with clinical
experience ranging from two to five years. The participants were six males and ten females. The
PMHNP received an in-service PowerPoint presentation about the QI project at the clinic on the
first day of week one. Participation was voluntary, and the criteria for inclusion of staff members
included a certified PMHNP nurse practitioner. Participants were made aware that no one would
be allocated by name or any form during this educational project. All participants were notified of
confidentiality with any given information, as none were required to write their names on the chart
review.
Ethical Considerations & Christian Worldview Integration
The quality improvement project focused on educating the practitioners about the
knowledge and frequency of use of the GAD-7 screening tool. Therefore, no patient intervention
was included at this time. I secured participants' confidentiality and privacy throughout the data
collection of the educational project. Permission to use the Iowa Model received from University
of the Iowa Hospitals. Permission was granted by the IRB at Liberty University to start the project.
Project participation was voluntary, and the participants could withdraw at any time from the
program. I ensured all the data identified remained anonymous. The computer for presentations
and the project was password protected. Before participating in this project, each participant
participated in a voluntary disclosure consent whose aim was to provide more information about
the quality improvement effort. I collected a signed site agreement and IRB approval from the
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university before starting the educational project. The CITI training was completed. The GAD-7
screening tool was accessible and free online and did not require permission from anyone before
use.
Dealing with people as God's creation required an understanding of the Christian
perspective. A worldview supports the necessary structure through which the world perceives the
uniqueness of an individual. The role of a PMHNP is to be truthful. Amer (2019) pointed out that
being sincere is crucial for building trust and demonstrating respect for individuals. Patients have
a great deal of faith in their providers, and they may feel that faith has been misplaced if they learn
of or suspect a lack of honesty and sincerity on the practitioner's part. It was a fundamental
conviction that the PMHNP should seek truth, see, understand, and experience learned knowledge
when assessing each patient. A human-centered worldview was essential during this EBP scholarly
project as God's considerations of first-order points of doctrine are non-negotiable in preserving
human subjects' authenticity. The Christian worldview considered humanity as the bearer of God's
divine image, being created in his image (Genesis 1:26).
Tools
The Microsoft Excel spreadsheet and GAD-7 screening tool were some of the tools needed
for this scholarly project. In addition, one of the most widely used anxiety measures in both
research and clinical practice is the GAD-7. The GAD-7 is a seven-item questionnaire that doctors
can use to quickly identify persons with GAD, as per the criteria listed in the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) manual. They indicate a good level
of sensitivity (89%) and specificity (82%) for a one-factor structure as the best fit, whereas others
claimed a two-factor model (Moreno et al., 2019; Seritan et al., 2018). It can be used for social
anxiety, post-traumatic stress disorder, panic disorder, and generalized anxiety disorder (GAD)
screening, diagnosis, and severity evaluation (where scores of 10 or higher indicate GAD). The
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American Psychiatric Association recommended the GAD-7 as a valid measure for determining
the severity of GAD in accordance with the revised DSM-5 criteria (APA, 2013). According to
research, GAD-7 tests can accurately diagnose the most prevalent anxiety disorders seen in
psychiatric outpatient mental health clinics while performing rapidly and improving time
efficiency (Sapra et al., 2020).
The principal investigator reviews the GAD-7 tool embedded in the EHR to gather
information regarding the deficiencies in the frequency of use of the screening tool at the outpatient
mental health clinic. The pre-chart review results determined PMHNPs' level of knowledge and
frequency of use of the GAD-7. The GAD-7 screening tool was a free questionnaire to assess
general anxiety (Hinz et al., 2017; Johnson et al., 2019). The GAD-7 tool is a seven-item
Generalized Disorder scale (GAD-7) used to screen for the severity of anxiety disorders in
inpatient and outpatient settings. It is based on the Diagnostic and Statistical Manual of Mental
Disorders- IV (DSM-IV) (Sapra et al., 2020). It is an attractive option used by many psychiatrists
and the general population due to its brief format, simple scoring, and public availability (Beard
& Björgvinsson, 2014). The GAD-7 screening tool was used during the scholarly project to support
proper diagnosis and uphold the standard of care.
Intervention
The necessity for long-term EBP improvement is evident, given the changing requirements
of the value-driven healthcare system. The GAD-7 is the primary evaluation tool used in this study,
which aligns with the early-engagement care delivery tenets. Early engagement is becoming a
reality of healthcare delivery as developing technology improves our ability to detect and act
before symptoms emerge or cause distress. The point of intervention can be much sooner for many
health conditions. By indicating when and where assistance is required more rapidly than is
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possible with current practice, the frequency of use of the GAD-7 screening tool to evaluate
patients is in line with the growing early-engagement care approach.
A thorough grasp of EBP is necessary for PMHNPs to participate actively, which drives
the practice transformation's effectiveness. This practice opportunity laid the groundwork for this
project, which was accepted once it was described for the university IRB and project site. This
project aimed to promote PMHNP involvement in the frequency of use of the GAD-7 screening
tool. During an on-site education session, the clinic's PMHNPs received EBP training on the
indication, usage, and interpretation of the GAD-7 screening tool. The presentation was developed
by the principal investigator with four years of experience as a family practitioner and a 15-year
work history in an inpatient mental health facility; thus, the materials utilized both clinical and
practical expertise, as the content was tailored to the clinic system and existing workflow. The
PMHNPs reviewed and signed a consent form to participate in the educational project during the
session, which took around five minutes (Appendix I). For 10 minutes, a pre-survey was conducted
verbally to determine the participant's familiarity with the GAD-7 screening tool. The GAD-7
education session was held in a conference room throughout the regularly scheduled PMHNP
meeting. Participants were informed that participation was optional and that no personal data
would be collected during the project. The educational event began with a roughly 45-minute
PowerPoint lecture-based APA criteria (2013), continued with a 10- to a 15-minute demonstration
of the GAD-7 tool in the EHR, and ended with a discussion session (Appendix G & H). The clinical
schedule, designed to minimize workflow concerns, continued after another ten minutes for all
participants. The post-verbal survey was carried out after the educational intervention. The
meeting was concluded after the PMHNPs were thanked for attending.
Timeline
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After the IRB's permission, the principal investigator conducted a pre-chart review from
August 22 through August 29 that covers three months (May to July 2022) worth of documentation
of the participants' use of the GAD-7 tool. The project was eight weeks, and the eighth week was
used for data analysis and the final writing of the paper. The principal investigator monitored the
PMHNPs via EHR chart review during the scholarly project on weeks one, three, five, and seven.
The chart was reviewed, and data were collected every other week for analysis. The principal
investigator used the pre-chart and week seven's post-chart review only to compare the means from
the same staff participants. The progress of the GAD-7 screening tool, as illustrated in figures 1
and 2 and tables 1 to 3, reveals significant improvement in the frequency of use of the tool.
Data Collection
After signed site approval by the medical director, the principal investigator explained the
inclusion criteria, the nature of the project, and the project's duration. The data were reviewed
using the MNC Wellness Center outpatient clinic system. The principal investigator gave each
PMHNP the chance to ask questions and address all their concerns in a user-friendly fashion. The
practitioners were made aware of a voluntary disclosure consent form to be completed. The data
did not include identified participants' information and was stored in a password-locked box in the
medical director's locked cabinet. The principal investigator reviews the post-chart data in the
EHR. The principal investigator took charge of the project activities by tracking all participants.
Data collected were imported into Microsoft Excel. The computer system was password protected
and shared no information with anyone.
Feasibility Analysis
The PMHNPs at an outpatient clinic's awareness and understanding of patient safety were
meaningfully revealed by this project. The site's computer and electronic medical record system
were the primary investigator's only data-gathering tools for the chart review. There were no
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associated costs for the chart reviews that were done at the site for the project. The MNC
Wellness center's educational intervention was provided without any further charge. The
organization's computers were open to the PMHNPs, who may use them to access the GAD-7
tool resources as needed.
Data Analysis
Data gathered from the pre-and post-chart review was analyzed and interpreted using
descriptive statistics. The effectiveness of the education presentation and any potential changes in
the practitioners' frequency of use of the GAD -7 screening tool were assessed by contrasting the
pre-and post-chart reviews. To evaluate the effect of the educational intervention on the
practitioners' frequency of use of the GAD-7 tool, the responses from all the participants were
compared. The scholarly project was accomplished using paired sample t-test analysis from the
pre-and post-chart data. Bar graphs and breakdown bars were used to display data results to make
them easier to understand and disseminate visually while highlighting the value of the GAD-7
screening tool.
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SECTION FOUR: RESULTS

The paired sample t-tests determined the differences between the pre-charts and post-charts
review of practitioners' improved knowledge and frequency of use of the GAD-7 screening tool to
support proper diagnosis and uphold the standard of care. The data from all reviewed charts were
anonymous, and no personal information was attached. All the data were analyzed using the
Microsoft Excel spreadsheet (see tables 1, 2, & 3 findings). Descriptive statistics using a Microsoft
Excel spreadsheet were used to compute the means and frequency of use (see figure 2). The
principal investigator inspected all data for errors by evaluating the pre-and post-chart review.
Descriptive Statistics
Eighteen PMHNP registered for the GAD-7 screening tool education training but only 16
practitioners attended, and no reasons were given for those absent. Using Microsoft Excel, I
performed a paired sample t-test to analyze the data and identify if there was any significant
difference between the pre-and the post-chart review. Further analysis of the post-chart review
showed significant improvement in staff knowledge and frequency of use of the GAD-7 screening
tool. The participants were labeled alphabetically from A to P and the scores as indicated in Figures
1 and 2, showed improvement across the board from the pre-chart review to the post-chart review.
In this participant sample (N = 16), the mean pre-chart review was 6. The pre-chart review scores
in Figure 1 showed the practitioners had some pre-knowledge of the use of the GAD-7 tool;
however, the knowledge was limited in the proper and frequency of use of the tool. The post-chart
review score of 23.6875 in Figure 1 showed significant improvement in the knowledge and
frequency of use of the GAD-7 screening tool. There were no noted unanticipated outcomes. See
below for details.
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Measurable Outcome 1
The first measurable outcome is the baseline frequency of use of the GAD-7 screening
tool. Before week one, the charts of 96 patients were reviewed for the use of the GAD-7 tool.
Frequency was measured in every other week data review.
Measurable Outcome 2
The second measurable outcome is the post-educational training on the frequency of use
of the GAD-7 tool of week one. All the post-week one GAD-7 screening tools used were
reviewed via EHR. All sixteen participants were present. The number of post-chart reviews for
week one was 144.
Measurable Outcome 3
The third measurable outcome of post-education training showed the frequency of use of
the GAD-7 tool for week three. The number of post-chart reviews for week three was 201.
Measurable Outcome 4
The fourth measurable outcome of post-education training showed the frequency of use
of the GAD-7 tool for week five. The number of post-chart reviews for week five was 322.
Measurable Outcome 5
The fifth measurable outcome of post-education training showed the frequency of use of
the GAD-7 tool for week seven. The number of post-chart reviews for week seven was 379. The
frequency was measured every other week for a total of seven weeks. The frequency was measured
in weeks using the t-test. The principal investigator determined the outcome using the paired
sample t-test analysis following the educational intervention. The post-chart review, including the
frequency of use of the GAD-7 screening tool, finalized the measurement of practitioners'
improved knowledge and frequency of use of the GAD-7 screening tool.
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Figure 1

Pre-and Post-Chart Review Scores
Participant
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P

Total

Mean Score

Pre-chart review score
8
10
8
6
4
4
5
8
7
5
9
2
4
3
6
7

Post-chart review score
24
25
26
28
24
20
22
24
24
20
25
23
22
26
21
25

144

379

6

23.6875

A paired sample t-test was used to compare the means of the pre-and post-chart review
from the same staff participants (see Figure 2). The null hypothesis H0 was that there would
be no difference between the means of the pre- and post-chart review scores. The alternative
hypothesis H1 was that there would be a difference (increase) between the means of the pre- and
post-chart review scores. The p-value ranging from 0 to 1 was obtained from the t-test. The pvalue of 0.05 is the probability of the observed data given that the null hypothesis is true; the
smaller the p-value, the greater the discrepancy (Sullivan, 2017; Tanha et al., 2017). The
statistical analysis t-test paired two samples for means as shown below revealed that the
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educational intervention significantly improved chart review scores of the staff knowledge and
frequency of use of the GAD-7 (t = 1.753050356, df = 15, p = 0.00000000000000261). The pvalue of 0.00000000000000261 was less than 0.05, which allowed the rejection of the null
hypothesis and implied the data results did not occur by chance. These results provide sufficient
evidence to conclude that the education was effective in improving PMHNP nurse practitioners’
knowledge and frequency of use of the GAD-7 screening tool.

Figure 2
t-Test: Paired Two Sample for Means

Variable 1
Mean
Variance
Observations
Pearson Correlation
Hypothesized Mean Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

6
5.2
16
0.365020358
0
15
-27.75933177
1.3064E-14
1.753050356
2.6128E-14
2.131449546

Variable 2
23.6875
5.029166667
16

Definition of Terms
The following words and phrases from the DNP project are outlined to support the
project outcomes.
Mean: The average or the most common value in a collection of numbers.
P-value: A measure of the probability that an observed difference could have occurred just by
random chance (Tanha et al., 2017; Sullivan, 2017). The lower the p-value, the greater the
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statistical significance of the observed difference. If a p-value is under .01, results are considered
statistically significant and if it’s below .005 they are considered highly statistically significant
(McLeod, 2019; Sullivan, 2017).
Paired sample t-test: a type of inferential statistics used to determine if there is a significant
difference between the means of two groups and to see if the differences (measured in means)
could have happened by chance (Liang et al., 2019)
Table 1
Findings: Pre-Chart Review
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SECTION FIVE
Implication for Practice
The positive impact on the practitioners of the educational intervention demonstrated
improved knowledge, proper diagnosis, and upholding the standard of care (Cullen et al., 2020;
Mughal et al., 2020). The outcome plan showed that the clinic needed to continue using the GAD7 screening tool daily to deliver EBP and support planned practice changes. Increased
practitioners’ knowledge improved the rate of acceptance of and devotion to practice changes,
created shared goals, and promoted common ascendancy (Cullen et al., 2020). The education
session for the mental health outpatient clinic fostered knowledge exchange amongst practitioners,
supporting proper diagnosis and upholding the standard of care. By enabling all practitioners to
participate, the clinic empowered its members to continue shared governance after the scholarly
project to keep the EBP spirit moving. This improved collective understanding of the proper daily
application of the tool, strengthening organizational culture and advancing the quality of healthcare
delivery to the needed population. Furthermore, the GAD-7 tool promotes efficient and accurate
diagnosis and supports standards of care mandated by the ANCC and Maryland board of nursing.
Sustainability
The Healthcare industry is evolving and, therefore, under intense competition to maintain
quality and improved EBP. The psychiatric mental health clinic adopted strategic planning of
excellence such as promotion and prevention, service, people, and governance (Sritoomma, 2018).
The sustainability of this QI project was a key factor. The intervention uses the clinic's current
EHR and doesn't need any additional maintenance funds. The information acquired was quickly
disseminated and encouraged future educational reinforcement or training by analyzing the preand post-chart. The clinic was well-positioned to readily capture, evaluate, and use data that could
influence decision-making at the individual and organizational level by applying MBC concepts
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to a crucial area of clinical practice and employing the GAD-7 tool with unambiguous outcome
measurements inside its EHR. The usefulness of using the GAD-7 screening tool inside the system
was clearly understood utilizing such data, which supports the GAD-7's continued usage as a
component of regular healthcare delivery.
Dissemination Plan
Every DNP project needs dissemination to ensure the study impacts people's social,
political, or economic lives. The results and conclusions of the research are brought to the attention
of stakeholders through dissemination, which improves understanding of how to use the research
(Marín-González et al., 2017). The scholarly project and its results will be shared at the end of
project completion at the MNC Wellness Center clinic with the providers on a date suitable for all
to meet. The clinic director will shelter a poster presentation in the training room that outlines the
project and its findings. I would like to submit and present the scholarly project to conferences
such as the Nurse Practitioner Association of Maryland and other mental health associations
nationwide. Ultimately, I will submit a manuscript of the educational project for potential
publication.
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are repeated
cross-sectional
samples and
longitudinal
data would be
important for
examining
changes in
anxiety such as
the time of
changes and the
associated
variables among
individuals. The
study was
designed to
examine
sociodemograph
ic differences in

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.
Yes.
Finding the
precursor to
identifying
the severity
of cooccurring
mental health
problems.
Focusing
resources
after
diagnosing
individuals to
reduce
anxiety is a
cost-effective
clinical and
public health
approach to
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Article 7
Hajebi et al.,
(2018)

Study
Purpose

The study
sought to assess
the prevalence
of major anxiety
disorders,
sociodemograph
ic correlates,
and mental
health service

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

A total of 7886
subjects
between 15
and 64 years
who could
understand
Persian
language

Metho
ds

Face--to-face
survey using
composite
International
Diagnostic
Interview

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

The overall
Level V
prevalence of
anxiety
disorders in the
past 12 months
as indicated in
the national
MHS was
found to be

Study
Limitations

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.

anxiety over
time but there
may have been
other variables
associated with
anxiety that
could have been
useful to
identify
vulnerable
subgroups.

lessening the
tide of this
problem.

The
study team did
not include
specific phobias
in the study
with the
rationale that
the impact was
less. The

Yes.
The research
study can
increase the
quality of
health care
services,
especially in
the outpatient
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Study
Purpose

utilization as
part of the
Iranian Mental
Health Survey

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

Study
Results

15.6%
elevated. A
higher rate of
all types of
anxiety was
found in
females
(19.4%)
compared to
males (12%)

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

Study
Limitations

prevalence of
specific phobias
in this study
was
underestimated.
Also, the Iran
MHS
implemented
the survey in a
single step
compared to
World Mental
Health Survey
which had been
administered in
two steps.
Language
barriers with
translating CIDI
to local

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.
setting by
enhancing
early
detection and
prompt
treatment of
the condition.
Thereby,
decreasing
the
occurrence
and risk of
the chronicity
of the
disease.
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Study
Purpose

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

Study
Limitations

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.

languages led to
an exclusion of
those who could
not understand
Persian. The
research could
not identify the
socioeconomic
status or
unemployment
and occurrence
of anxiety
disorders to
analyze the role
of influential
factors.
Article 8

The evaluation
of an electronic
health record
[HER] tool for

Implemented
the behavioral
health e-suite
across six

A convergent
mixed-

The
implementatio
n of behavioral
health

Level-III

The sample size
of clinics was
small, and the
generalizability

Yes
Implementing
the screening
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Study
Purpose

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

Study
Results

Jetelina et
al., (2018)

integrated
behavioral
health in
primary care.

Oregon
federally
qualified
community
health centers.

methods
proof-of-study

screening tools
(PHQ-9 &
GAD-7) in
primary
settings
improve the
process of care
for patients.

Article 9

To investigate
the internal
consistency,
reliability, and
validity in a
large of
heterogeneous

N=1201 both
in and
outpatient
patients
completed

Paper and
pencil

The GAD-7
has excellent
internal
consistency
and one-factor
structure in a
heterogeneous

Johnson et
al., 2019

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

Level III

Study
Limitations

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.

of the study was
limited. The
study lacks
resources that
provide
implementation
support to
clinics and no
test was done on
how to best
implement the
BH e-Suite

tool GAD-7
as part of the
EHR will
improve
overall
whole-person
care.

Lack of specific
diagnostic
information for
much of the
sample. Since
the BAI was
used to calculate
the cutoff for an

Yes.
Implementing
the GAD-7 as
a routine
screening tool
in the
outpatient

70

Artic
le Title,
Author, etc.
(Current
APA
Format)

Study
Purpose

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

psychiatric
patients

Article 10
Ren et al.,
(2021)

The relations
between several
factors of
intolerance of
uncertainty and
symptoms of
generalized
anxiety
disorder: a

A total of 624
university
students from
Xijing
University
participated in
the study

Crosssectional data

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

Study
Limitations

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.

clinical
population.

anxiety
disorder, they
could not
investigate if the
GAD-7
performed
differently with
different
specific
diagnostic
groups

clinic will
improve the
patients’’
overall health
care.

The study
Level IV
revealed
potential
pathways
through which
intolerance of
uncertainty
(IU) factors are
caused by

Recruited
Chinese
University
students and
reporting factors
of IU and
symptoms of
GAD that span
the full range of

Yes.
Recognizing
signs and
symptoms of
anxiety is the
first approach
to proper
diagnosis and
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Study
Purpose

network
analysis

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

Study
Results

symptoms of
GAD. Also,
the findings
highlight how
including
hypothesized
risk factors
may enrich
symptom
networks to
gain a precise
understanding
of processes in
mental
disorders.

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

Study
Limitations

normal to
abnormal limit
the
generalizability
of the findings.
Also, the crosssectional data
applied to
construct the
network
structure of
factors of IU
and symptoms
of GAD impede
claims about
causality. The
symptoms were
single-item,
self-reported
assessments,

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.
a better
treatment
plan.
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Study
Purpose

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

Study
Limitations

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.

which may be
limited to
capturing
clinical
occurrences.
Article 11
Moreno et
al., (2018)

Factorial
Invariance of a
computerized
version of the
GAD-7 across
various
demographic
groups and over
time in primary
care patients.

A total of 1255
patients
completed the
computerized

Cohort study

The GAD-7
screening tool
was found to
both have
reliability and
validity for
anxiety
symptom
screening and
monitor
responses
regarding
treatment.

Level IV

Unable to
generalize all
primary care
patients’ results
since the
general
practitioners
only included
those suffering
from emotional
disorders

Yes.
The GAD-7
screening tool
is an
appropriate
tool to screen
anxiety that
could be
incorporated
into the
outpatient
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Article 12
Shevlin et
al., 2022

Study
Purpose

To test for
differential item
functioning
(DIF) on the
PHQ-9 and
GAD-7 items
based on age,
sex (males and
females), and
country.

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

N=6,054 from
nationally
representative
surveys in the
UK, Ireland,
Spain, Ireland,
and Italy

Metho
ds

Qualtrics
survey
platform, using
stratified quota
sampling

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

The PHQ-9
Level I
and GAD-7
scores were
found to be
unidimensional
, reliable, and
largely free of
DIF in data
from the four
large
nationally
represented
samples of the
general
population of
the UK,
Ireland, Italy,
and Spain.

Study
Limitations

Surveys were
not conducted at
the same time,
data was
collected at onetime point
which interferes
with the
invariance
scores reading
across time. The
analyses only
tested for
uniform DIF
rather than nonuniform DIF

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.
Yes.
The research
shows that
GAD-7 is a
reliable tool
to assess
anxiety in
outpatient
mental health
clinics.
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Article 13
Sinnema et
al., (2018)

Study
Purpose

To explore
which patient
and general
practitioners
[GPs]
characteristics
are associated
with the
recognition of
anxiety and
depression

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

444 patients

Metho
ds

Cluster
Randomized
controlled trial

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

Patients with a Level II
report of
perceived need
for
psychological
care (OR=2.54,
95% CI 1,604.03) and those
with higher
distress scores
were more
likely to be
recognized.
Those patients
with a
perceived need
for
physiological
care and high
distress were

Study
Limitations

The inherent
methodology is
limited when
using medical
records. The
self-report
questionnaire,
the EK-10, was
used as a
reference
standard for
adding the
participants to
the study.
Although EK10 is a
screening
instrument for
anxiety and
depressive

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.
Yes.
Implementing
a reliable
reference
standard for
the diagnosis
will add
confidence in
GPs’ ability
to identify
anxiety and
provide
whole-person
treatment.

75

Artic
le Title,
Author, etc.
(Current
APA
Format)

Study
Purpose

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

more likely to
be noticed by
their general
practitioner for
having anxiety
and depression.

Article 14
Spitzer et al.,
(2006)

A brief measure
for assessing
Generalized
Anxiety
disorder the
GAD-7

A total of 2740
adult patients
completed the
study
questionnaire

Crosssectional study
using a
questionnaire.

A 7-item
anxiety scale
(GAD-7) had
good
reliability, as
well as the
criterion,
construct,
factorial, and
procedural
validity.

Study
Limitations

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.

disorder in
general practice,
a reliable
instrument for
standardized
diagnosis may
have been
preferable.
Level IV

The tool focuses
on only one
anxiety type and
provides only
probable
diagnoses that
need further
evaluation. The
study needs to
determine the
responsiveness
of the GAD-7

Yes.
The GAD-7
tool is a valid
and efficient
tool for
screening
GAD and
assessing its
severity in
clinical
practice as
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Article 15
Toussaint et
al., (2020)

Study
Purpose

To investigate
sensitivity to
change and
minimal
clinically
important
differences of
the GAD-7
questionnaire.

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

N-261 patients Evaluatorwere included blinded,
in the analyses. prospective,
parallel-group,
randomized
clinical trial

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

The results
Level II.
show that the
GAD-7 tool is
sensitive to
detect a change
in
psychopatholo
gy throughout
the treatment.

Study
Limitations

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.

across time due
to its crosssectionality.

well as
research. It
has
generalizabili
ty to
outpatient
practice.

The Hamilton
Rating Scale for
Depression
(HRSD-24)
score might not
be the ideal
external
criterion for
treatment
improvement.
However, the
sample
evaluated is

Yes.
It is
important to
recognize the
comorbidity
and assess
and treat it
accordingly.
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Artic
le Title,
Author, etc.
(Current
APA
Format)

Study
Purpose

Sample
(Characteristi
cs of the
Sample:
Demographics
, etc.)

Metho
ds

Study
Results

Lev
el of
Evidence
(Use
Melnyk
Framewor
k)

Study
Limitations

detected as
useful in the
treatment
response in
terms of
symptoms of
anxiety.

Woul
d Use as
Evidence to
Support a
Change?
(Yes or No)
Provide
Rationale.
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Appendix E: Iowa Model of Evidence-Based Practice
Seven Steps of Iowa Model of Evidence-Based Practice (EBP)

Note. From “Introducing Evidence into Nursing Practice: Using the Iowa Model,” by Doody, C.
M., & Doody, O. (2011). Introducing evidence into nursing practice: Using the IOWA
model. British Journal of Nursing, 20(11), 661-664.
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Appendix G: Generalized Anxiety disorder screening tool (GAD-7)
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Appendix H: Anxiety Toolkit Contents Guidelines for using GAD-7
GAD-7 Anxiety Score Proposed Treatment Action
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Appendix I: Disclosure Consent
GAD-7 Education at MNC Wellness Center
Voluntary Disclosure Consent

